172@29@17@106!~!172@29@0@53!~!|news|tags|alembic-pharma.html|page-4|!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
alembic pharma
Jump to
128 Results Found
  • Bull's Eye: Buy IOC, Nakoda, BOI, YES Bank, Arvind Dec 23, 2013 08:57 AM IST

    Bull's Eye: Buy IOC, Nakoda, BOI, YES Bank, Arvind

    Pankaj Jain of Sunteck Wealthmax recommends buying GMR Infrastructure with a target of Rs 24.95 and Peninsula Land with a target of Rs 43.45.

  • Bull's Eye: Buy MRPL, KPIT Tech; sell PTC India, Voltas Nov 08, 2013 08:59 AM IST

    Bull's Eye: Buy MRPL, KPIT Tech; sell PTC India, Voltas

    Krish Subramanium of Asit C Mehta advises buying Mangalore Refinery and Petrochemicals for a target price of Rs 45.75 and Torrent Pharma for a target price of Rs 512.

  • Bull's Eye: Buy Titan, Bajaj Finance; short LIC Housing Oct 29, 2013 09:04 AM IST

    Bull's Eye: Buy Titan, Bajaj Finance; short LIC Housing

    Dharmesh Kant of India Nivesh Securities advises buying Bajaj Finance with a target price of Rs 1,320 and JB Chemicals with a target price of Rs 99.

  • Alembic Pharma consolidated Sep '13 sales at Rs 484.28 crore Oct 26, 2013 02:10 PM IST

    Alembic Pharma consolidated Sep '13 sales at Rs 484.28 crore

    Alembic Pharmaceuticals has reported a sales turnover of Rs 484.28 crore and a net profit of Rs 61.64 crore for the quarter ended Sep '13

  • Bull's Eye: Buy Canara Bank, Jubilant Foodworks, Sesa Goa Sep 24, 2013 08:56 AM IST

    Bull's Eye: Buy Canara Bank, Jubilant Foodworks, Sesa Goa

    Saurabh Mittal of Swadeshi Credits recommends buying Motherson Sumi with a target price of Rs 237 and Canara Bank with a target price of Rs 232.

  • Buy Alembic Pharma; target of Rs 160: Firstcall Research Sep 16, 2013 12:35 PM IST

    Buy Alembic Pharma; target of Rs 160: Firstcall Research

    Firstcall Research is bullish on Alembic Pharma and has recommended buy rating on the stock with a target of Rs 160 in its September 12, 2013 research report.

  • Bull's Eye: Buy Sintex, Voltas, Eros International, PFC Sep 16, 2013 09:01 AM IST

    Bull's Eye: Buy Sintex, Voltas, Eros International, PFC

    Prakash Diwan of Altamount Capital Management recommended buying Hindustan Zinc with a target price of Rs 129.90 and Alembic Pharma with a target price of Rs 145.50.

  • Alembic Pharma consolidated Jun '13 sales at Rs 426.37 crore Aug 08, 2013 12:42 PM IST

    Alembic Pharma consolidated Jun '13 sales at Rs 426.37 crore

    Alembic Pharmaceuticals has reported a sales turnover of Rs 426.37 crore and a net profit of Rs 46.64 crore for the quarter ended Jun '13

  • See 20% EBITDA growth in FY14: Alembic Pharma Aug 07, 2013 03:50 PM IST

    See 20% EBITDA growth in FY14: Alembic Pharma

    In an interview to CNBC-TV18, Amin adds that the company, despite the drug pricing policy, will grow at 15 percent.

  • TCS, Lupin, Asian Paints to get astrological support: Gupta Aug 02, 2013 10:12 AM IST

    TCS, Lupin, Asian Paints to get astrological support: Gupta

    According to Satish Gupta of astrostocktips.in, paints stocks like Asian Paints, Berger Paints and technology stocks like Hexaware Technologies, Tata Consultancy Services will get astrological support.

  • HUL, Lupin, Bata to get astrological support: Gupta Aug 01, 2013 11:09 AM IST

    HUL, Lupin, Bata to get astrological support: Gupta

    According to Satish Gupta of astrostocktips.in, personal care stocks like Hindustan Unilever, Dabur India and pharma stocks like Lupin, Divis Laboratories, Cipla will get astrological support.

  • Wipro, Bata, TCS to get astrological support: Gupta Jul 31, 2013 10:38 AM IST

    Wipro, Bata, TCS to get astrological support: Gupta

    Technologystocks like Wipro, HCL Technologies and leather stocks like Bata India, Sreeleathers will get astrological support, says Satish Gupta of astrostocktips.in.

  • Wipro, HCL Tech, Cipla to get astrological support: Gupta Jul 30, 2013 10:02 AM IST

    Wipro, HCL Tech, Cipla to get astrological support: Gupta

    According to Satish Gupta of astrostocktips.in, technology stocks like Wipro, HCL Technologies, Tata Consultancy Services and pharma stocks like Divis Laboratories, Sun Pharmaceutical Industries to get astrological support.

  • UCB files cases against Ranbaxy, Glenmark, and others Jul 22, 2013 08:36 PM IST

    UCB files cases against Ranbaxy, Glenmark, and others

    Global biopharma company, UCB filed separate cases against 15 drug makers including Ranbaxy, Aurobindo, Zydus, Sun Pharma, Glenmark, Alembic Pharmaceuticals.

  • Buy Chambal Fert, Alembic Pharma; sell HPCL: Mukadam Jul 09, 2013 02:30 PM IST

    Buy Chambal Fert, Alembic Pharma; sell HPCL: Mukadam

    Shahina Mukadam of Varun Capital recommends buying Chambal Fertilisers and Chemicals with a target of Rs 40 and advises to sell Hindustan Petroleum Corporation with a target of Rs 227.

  • Bull's Eye: Buy Alembic Pharma, Reliance Power, PTC India Jul 09, 2013 08:52 AM IST

    Bull's Eye: Buy Alembic Pharma, Reliance Power, PTC India

    Sharmila Joshi of Peerless Securities advised buying Alembic Pharma with a target price of Rs 168 and Escorts with a target price of Rs 80.

  • Bull's Eye: Buy IVRCL, GSFC, Tech Mahindra; short Petronet Jun 20, 2013 08:54 AM IST

    Bull's Eye: Buy IVRCL, GSFC, Tech Mahindra; short Petronet

    Rajesh Agarwal of Eastern Financiers advised buying Mahindra Ugine for a target price of Rs 93 and IVRCL for a price target of Rs 17.50.

  • Not impacted by Ranbaxy's negative news: Alembic Pharma May 29, 2013 04:38 PM IST

    Not impacted by Ranbaxy's negative news: Alembic Pharma

    Ranbaxy shares declined a further 2 percent on Wednesday morning after a media report said a prominent hospital in Mumbai had advised doctors to stop using the pharma company's drugs.

  • See 100-120 bps margin improvement in FY14: Alembic Pharma May 06, 2013 01:33 PM IST

    See 100-120 bps margin improvement in FY14: Alembic Pharma

    Alembic Pharma is hopeful to increase operating margin by 100-120 basis points in current financial year on the back of strong growth in international and domestic generic business.

  • Avoid Alembic Pharma, says SP Tulsian Mar 11, 2013 07:57 PM IST

    Avoid Alembic Pharma, says SP Tulsian

    SP Tulsian, sptulsian.com advises traders to avoid Alembic Pharma at current levels.

  • Alembic sees 1% rise in EBITDA on antidepressant drug nod Mar 06, 2013 01:25 PM IST

    Alembic sees 1% rise in EBITDA on antidepressant drug nod

    Alembic Pharmaceuticals expects 100 basis points improvement in its EBITDA as it has earned exclusive rights to sell Pristiq generic tablets for 24 Months.

  • Alembic Pharma likely to touch Rs 82-84, says Tulsian Mar 06, 2013 12:48 PM IST

    Alembic Pharma likely to touch Rs 82-84, says Tulsian

    SP Tulsian of sptulsian.com advised buying Alembic Pharma at around Rs 82-84. He expects the stock to hit these levels in a week.

  • Buy Alembic Pharma; target Rs 119: Nirmal Bang Mar 06, 2013 11:41 AM IST

    Buy Alembic Pharma; target Rs 119: Nirmal Bang

    Nirmal Bang is bullish on Alembic Pharma and has recommended buy rating on the stock with a target price of Rs 119, in its March 05, 2013 research report.

  • Bull's eye: Buy IndusInd Bank, NHPC, SKS Micro, PFC Mar 06, 2013 08:27 AM IST

    Bull's eye: Buy IndusInd Bank, NHPC, SKS Micro, PFC

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Alembic Pharma has target of Rs 100: SP Tulsian Mar 05, 2013 07:38 PM IST

    Alembic Pharma has target of Rs 100: SP Tulsian

    Alembic Pharma has target of Rs 100, says SP Tulsian, sptulsian.com

Sections